{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:08:40Z","timestamp":1778864920993,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","award":["DK064466"],"award-info":[{"award-number":["DK064466"]}],"id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK093954"],"award-info":[{"award-number":["R01 DK093954"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK127308"],"award-info":[{"award-number":["DK127308"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK097512"],"award-info":[{"award-number":["P30DK097512"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["I01BX001733"],"award-info":[{"award-number":["I01BX001733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010249","name":"School of Medicine, Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcte.2026.100438","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:40:48Z","timestamp":1775058048000},"page":"100438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of temperature and preservative selection on C-peptide degradation in randomly voided urine"],"prefix":"10.1016","volume":"44","author":[{"given":"Eli H.","family":"Hagedorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron R.","family":"Rostron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Acton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallory","family":"Oswalt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert V.","family":"Considine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7764-8663","authenticated-orcid":false,"given":"Carmella","family":"Evans-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2026.100438_b0005","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.3390\/ijms22126403","article-title":"Role of insulin in health and disease: an update","volume":"22","author":"Rahman","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcte.2026.100438_b0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcte.2026.100438_b0015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diabetes.53.1.250","article-title":"C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001","volume":"53","author":"Palmer","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2026.100438_b0020","first-page":"16","article-title":"Insulin, insulin antibodies and insulin autoantibodies","volume":"49","author":"Winter","year":"2017","journal-title":"MLO Med Lab Obs"},{"key":"10.1016\/j.jcte.2026.100438_b0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","article-title":"A practical review of C-peptide testing in diabetes","volume":"8","author":"Leighton","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jcte.2026.100438_b0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","article-title":"Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance","volume":"41","author":"Van Cauter","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2026.100438_b0035","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dbi23-0012","article-title":"Evidence for C-peptide as a validated surrogate to predict clinical benefits in trials of disease-modifying therapies for type 1 diabetes","volume":"73","author":"Latres","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2026.100438_b0040","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S2213-8587(21)00019-X","article-title":"Anti-interleukin-21 antibody and liraglutide for the preservation of \u03b2-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"von Herrath","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcte.2026.100438_b0045","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1056\/NEJMoa2006136","article-title":"Golimumab and beta-cell function in youth with new-onset type 1 diabetes","volume":"383","author":"Quattrin","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2026.100438_b0050","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/dc18-0494","article-title":"Low-dose anti-thymocyte globulin (ATG) preserves \u03b2-cell function and improves hba1c in new-onset type 1 diabetes","volume":"41","author":"Haller","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2026.100438_b0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/dc12-0836","article-title":"Lessons from the mixed-meal tolerance test","volume":"36","author":"Besser","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2026.100438_b0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/dme.12159","article-title":"The clinical utility of C-peptide measurement in the care of patients with diabetes","volume":"30","author":"Jones","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2026.100438_b0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/diab.26.1.30","article-title":"Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine","volume":"26","author":"Horwitz","year":"1977","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2026.100438_b0070","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00431-020-03606-7","article-title":"Urinary C-peptide creatinine ratio to differentiate type 2 diabetes mellitus from type 1 in pediatric patients","volume":"179","author":"Elzahar","year":"2020","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcte.2026.100438_b0075","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1373\/clinchem.2009.129312","article-title":"Stability and reproducibility of a single-sample urinary C-peptide\/creatinine ratio and its correlation with 24-h urinary C-peptide","volume":"55","author":"McDonald","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jcte.2026.100438_b0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/dc10-2114","article-title":"Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes","volume":"34","author":"Besser","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2026.100438_b0085","first-page":"181","article-title":"Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes","volume":"14","author":"Besser","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcte.2026.100438_b0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1464-5491.2011.03428.x","article-title":"Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes","volume":"29","author":"Bowman","year":"2012","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"10.1016\/j.jcte.2026.100438_b0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.17925\/EE.2022.18.1.2","article-title":"Diagnostic test accuracy of urine C-peptide creatinine ratio for the correct identification of the type of diabetes: a systematic review","volume":"18","author":"Pappachan","year":"2022","journal-title":"TouchREVIEWS Endocrinol"},{"key":"10.1016\/j.jcte.2026.100438_b0100","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/dme.13186","article-title":"Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of \u03b2-cell function in the first year after diagnosis of Type 1 diabetes","volume":"33","author":"Tatovic","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2026.100438_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1052794","article-title":"Application of urine C-peptide creatinine ratio in type 2 diabetic patients with different levels of renal function","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jcte.2026.100438_b0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0009-8981(97)00080-6","article-title":"Stability of urine creatinine1","volume":"264","author":"Spierto","year":"1997","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jcte.2026.100438_b0115","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/dc13-1266","article-title":"Home urine C-peptide creatinine ratio can be used to monitor islet transplant function","volume":"37","author":"Oram","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2026.100438_b0120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2337\/dc10-1293","article-title":"Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}\/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes","volume":"34","author":"Besser","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2026.100438_b0125","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/dc23-0675","article-title":"Teplizumab: a disease-modifying therapy for type 1 diabetes that preserves \u03b2-cell function","volume":"46","author":"Herold","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2026.100438_b0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcte.2026.100438_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108938","article-title":"Kinetics of C-peptide during mixed meal test and its value for treatment optimization in monogenic diabetes patients","volume":"178","author":"Stankute","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcte.2026.100438_b0140","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.2215\/CJN.08800816","article-title":"The influence of processing and storage conditions on renal protein biomarkers","volume":"11","author":"Giesen","year":"2016","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"10.1016\/j.jcte.2026.100438_b0145","first-page":"919","article-title":"Sodium carbonate is a useful new preservative for collecting 24-hr urine samples to measure urinary C-peptide","volume":"46","author":"Ogawa","year":"2003","journal-title":"J Jpn Diabetes Soc"},{"key":"10.1016\/j.jcte.2026.100438_b0150","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/metabo9100203","article-title":"Influence of storage conditions and preservatives on metabolite fingerprints in urine","volume":"9","author":"Wang","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.jcte.2026.100438_b0155","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1021\/pr070328s","article-title":"Practical points in urinary proteomics","volume":"6","author":"Thongboonkerd","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jcte.2026.100438_b0160","first-page":"003","article-title":"Optimizing urine processing protocols for protein and metabolite detection","volume":"2015","author":"Siddiqui","year":"2015","journal-title":"J Proteomics Bioinform"},{"key":"10.1016\/j.jcte.2026.100438_b0165","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2337\/dc15-2849","article-title":"Elevations in the fasting serum proinsulin-to-C-peptide ratio precede the onset of type 1 diabetes","volume":"39","author":"Sims","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2026.100438_b0170","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/dc17-2625","article-title":"Proinsulin secretion is a persistent feature of type 1 diabetes","volume":"42","author":"Sims","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2026.100438_b0175","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/pdi.2508","article-title":"Feasibility of using urinary c-peptide to guide diabetes management in a district general hospital type 1 diabetes population","volume":"41","author":"Redford","year":"2024","journal-title":"Pract Diabetes"},{"key":"10.1016\/j.jcte.2026.100438_b0180","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1373\/clinchem.2007.088823","article-title":"Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometry","volume":"53","author":"Brinkman","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.jcte.2026.100438_b0185","article-title":"Stability of urinary albumin and creatinine after 12 months storage at \u221220\u00a0\u00b0C and \u221280\u00a0\u00b0C","volume":"15","author":"Chapman","year":"2019","journal-title":"Pract Lab Med"},{"key":"10.1016\/j.jcte.2026.100438_b0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1258\/acb.2009.009247","article-title":"Urinary proteases degrade albumin: implications for measurement of albuminuria in stored samples","volume":"47","author":"Kania","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jcte.2026.100438_b0195","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1021\/pr070311+","article-title":"Bacterial overgrowth affects urinary proteome analysis: recommendation for centrifugation, temperature, duration, and the use of preservatives during sample collection","volume":"6","author":"Thongboonkerd","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jcte.2026.100438_b0200","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/dme.13095","article-title":"Urinary C\u2013peptide analysis in an intervention study: experience from the DEFEND\u20132 otelixizumab trial","volume":"33","author":"Ambery","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2026.100438_b0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10858-011-9489-1","article-title":"Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks","volume":"49","author":"Bernini","year":"2011","journal-title":"J Biomol NMR"},{"key":"10.1016\/j.jcte.2026.100438_b0210","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1258\/acb.2011.011164","article-title":"The impact of gender on urine C-peptide creatinine ratio interpretation","volume":"49","author":"Thomas","year":"2012","journal-title":"Ann Clin Biochem"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623726000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623726000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:18:07Z","timestamp":1778861887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623726000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"alternative-id":["S2214623726000098"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2026.100438","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of temperature and preservative selection on C-peptide degradation in randomly voided urine","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2026.100438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100438"}}